NCT02833753 2022-05-31
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
University of Massachusetts, Worcester
Phase 1 Completed
University of Massachusetts, Worcester
Wake Forest University Health Sciences
Wake Forest University Health Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)